News
Third-Party Logistics in Pharma: The Compliance Blind Spot You Can’t Afford to Ignore
Third-party logistics providers (3PLs) are the lifeblood of modern pharmaceutical distribution. They move products, manage storage, and keep supply chains running. Yet too often licensing is treated as a formality, an afterthought to the more visible aspects of...
A Revolution in Medicine, a Maze of Regulations: Virtual Manufacturing in the Pharmaceutical Industry
The pharmaceutical industry is on the cusp of a quiet revolution. No longer is the path from lab bench to patient bedside a linear journey controlled by a single, monolithic company. A new model is emerging: virtual manufacturing. These companies, unburdened by the...
Wholesale Drug Distributor Licensing: What Every Company Needs to Know
Behind every prescription that reaches a patient is a complex and highly regulated supply chain. At the center of it are wholesale drug distributors. These companies do not manufacture or prescribe medications. Instead, they are the logistical experts who make sure...
Why Routine Inspections Matter More Than Ever
Staying Inspection-Ready: How Routine Facility Inspections Keep Your Licenses on TrackAs regulatory expectations continue to evolve, pharmaceutical and medical device companies must stay proactive to maintain uninterrupted operations. One area of increasing scrutiny...
The Uncharted Waters: Navigating States Without Formal Registration and Your Path to Compliance
Beyond the Register: Proactive Compliance in States Without Formal Drug Price Transparency RegistrationsIn our previous posts, we explored the critical role of state drug price transparency registrations, distinguishing between annual and one-time requirements. Today,...
Navigating the Nuances: Annual vs. One-Time Drug Price Transparency Registrations
Annual vs. One-Time: Deconstructing State Drug Price Transparency Registration RequirementsIn Part 1 of our series, we introduced the critical role of state drug price transparency registrations in ensuring compliance. Now, we'll dive deeper into the two primary types...
Beyond the Report: Why State Drug Price Transparency Registrations Are Crucial for Compliance
In the increasingly complex world of drug price transparency, merely preparing your data for submission isn't enough. A foundational, yet often underestimated, element of compliance lies in understanding and managing the diverse state-specific registration processes....
The High Stakes of Non-Compliance: Why DSCSA Is Non-Negotiable for Pharmaceutical and Life Sciences Companies
In the intricate world of pharmaceutical and life sciences supply chains compliance is not merely a checkbox, it is the bedrock of your business's survival. While many companies operate under the dangerous illusion of safety the reality is stark. Non-compliance with...
⚠️ Important Update: Puerto Rico Halts Non-Resident Licensing Program
The pharmaceutical and medical device industries are no strangers to dynamic regulatory landscapes. However, a recent and significant development from the Puerto Rico Department of Health (PR DOH) demands immediate attention from companies operating, or planning to...